Intelligence Platform
Patents
Browse 308 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7226602
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
granted patentUS 7201907
Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines
granted patentUS 7141405
Chimeric GB virus B (GBV-B)
granted patentUS 7115262
Chimeric protein for prevention and treatment of HIV infection
granted patentUS 7070959
Modified chimeric polypeptides with improved pharmacokinetic properties
granted patentUS 7070771
Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
granted patentUS 7045313
Recombinant vaccinia virus containing a chimeric gene having foreign DNA flanked by vaccin
expired patentUS 7009044
HCV/BVDV chimeric genomes and uses thereof
expired patentUS 6800286
Chimeric fibroblast growth factor proteins, nucleic acid molecules, and uses thereof
expired patentUS 6689367
Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleot
expired patentUS 6676936
Chimeric and/or growth-restricted flaviviruses
expired patentUS 6660273
Chimeric vaccine against tick-borne encephalitis virus
expired patentUS 6518061
IL-13 receptor specific chimeric proteins and uses thereof
expired patentUS 6497884
Chimeric vaccine against tick-borne encephalitis virus
expired patentUS 6280734
Simian-human HAV having a chimeric 2C protein
expired patentUS 6184024
Chimeric and/or growth-restricted flaviviruses
expired patentUS 6146643
Human/simian chimeric hepatitis A virus vaccine
expired patentUS 6099847
Chimeric Gag pseudovirions
expired patentUS 6051232
Chimeric MHC class I antigens for inducing allograft tolerance
expired patentUS 6011002
Circularly permuted ligands and circularly permuted chimeric molecules
expired